Characterization of type I receptors for transforming growth factor-beta and activin
- PMID: 8140412
- DOI: 10.1126/science.8140412
Characterization of type I receptors for transforming growth factor-beta and activin
Abstract
Transforming growth factor-beta (TGF-beta) and activin exert their effects by binding to heteromeric complexes of type I and type II receptors. The type II receptors for TGF-beta and activin are transmembrane serine-threonine kinases; a series of related receptors, denoted activin receptor-like kinase (ALK) 1 to 5, have recently been identified, and ALK-6 is described here. ALK-5 has been shown to be a functional TGF-beta type I receptor. A systematic analysis revealed that most ALKs formed heteromeric complexes with the type II receptors for TGF-beta and activin after overexpression in COS cells; however, among the six ALKs, only ALK-5 was a functional TGF-beta type I receptor for activation of plasminogen activator inhibitor-1, and only ALK-2 and ALK-4 bound activin with high affinity.
Similar articles
-
Identification of human activin and TGF beta type I receptors that form heteromeric kinase complexes with type II receptors.Cell. 1993 Nov 19;75(4):671-80. doi: 10.1016/0092-8674(93)90488-c. Cell. 1993. PMID: 8242742
-
Identification of type I receptors for osteogenic protein-1 and bone morphogenetic protein-4.J Biol Chem. 1994 Jun 24;269(25):16985-8. J Biol Chem. 1994. PMID: 8006002
-
Molecular characterization of a type I serine-threonine kinase receptor for TGF-beta and activin in the rat pituitary tumor cell line GH3.Exp Cell Res. 1995 Jan;216(1):208-14. doi: 10.1006/excr.1995.1026. Exp Cell Res. 1995. PMID: 7813622
-
Three-finger toxin fold for the extracellular ligand-binding domain of the type II activin receptor serine kinase.Nat Struct Biol. 1999 Jan;6(1):18-22. doi: 10.1038/4887. Nat Struct Biol. 1999. PMID: 9886286 Review.
-
Serine/threonine kinase receptors.Prog Growth Factor Res. 1994;5(1):55-72. doi: 10.1016/0955-2235(94)90017-5. Prog Growth Factor Res. 1994. PMID: 8199354 Review.
Cited by
-
TGFβRIIb mutations trigger aortic aneurysm pathogenesis by altering transforming growth factor β2 signal transduction.Circ Cardiovasc Genet. 2012 Dec;5(6):621-9. doi: 10.1161/CIRCGENETICS.112.964064. Epub 2012 Oct 24. Circ Cardiovasc Genet. 2012. PMID: 23099432 Free PMC article.
-
Down-regulated hsa_circ_0067934 facilitated the progression of gastric cancer by sponging hsa-mir-4705 to downgrade the expression of BMPR1B.Transl Cancer Res. 2019 Dec;8(8):2691-2703. doi: 10.21037/tcr.2019.10.32. Transl Cancer Res. 2019. PMID: 35117027 Free PMC article.
-
BMP-2 antagonists emerge from alterations in the low-affinity binding epitope for receptor BMPR-II.EMBO J. 2000 Jul 3;19(13):3314-24. doi: 10.1093/emboj/19.13.3314. EMBO J. 2000. PMID: 10880444 Free PMC article.
-
ALK2 mutation in a patient with Down's syndrome and a congenital heart defect.Eur J Hum Genet. 2011 Apr;19(4):389-93. doi: 10.1038/ejhg.2010.224. Epub 2011 Jan 19. Eur J Hum Genet. 2011. PMID: 21248739 Free PMC article.
-
The type I TGF-beta receptor is covalently modified and regulated by sumoylation.Nat Cell Biol. 2008 Jun;10(6):654-64. doi: 10.1038/ncb1728. Epub 2008 May 11. Nat Cell Biol. 2008. PMID: 18469808 Free PMC article.
Publication types
MeSH terms
Substances
Associated data
- Actions
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
